Hasil Pencarian - Sandra Lockmer
- Menampilkan 1 - 4 hasil dari 4
-
1
Minimal residual disease status is the prognostic determinant following high‐dose treatment for patients with multiple myeloma oleh Hareth Nahi, Gabriel Afram, Katarina Uttervall, Sandra Lockmer, Love Tätting, Gösta Gahrton, Muhammad Kashif, Evren Alici, Olga Stromberg, Monika Klimkowska, Johan Lund
Diterbitkan 2023-11-01
Artikel -
2
Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden oleh Caroline E. Weibull, Tove Wästerlid, Björn Engelbrekt Wahlin, Per-Ola Andersson, Sara Ekberg, Sandra Lockmer, Gunilla Enblad, Michael J. Crowther, Eva Kimby, Karin E. Smedby
Diterbitkan 2023-03-01
Artikel -
3
A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy oleh Chloé B. Steen, Ellen Leich, June H. Myklebust, Sandra Lockmer, Jillian F. Wise, Björn E. Wahlin, Bjørn Østenstad, Knut Liestøl, Eva Kimby, Andreas Rosenwald, Erlend B. Smeland, Harald Holte, Ole Christian Lingjærde, Marianne Brodtkorb
Diterbitkan 2019-10-01
Artikel -
4
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment oleh Wendy B. C. Stevens, G. Tjitske Los-de Vries, Carole Langois-Jacques, Andrew J. Clear, Phylicia Stathi, Birgitta Sander, Andreas Rosenwald, Maria Calaminici, Eva Hoster, Wolfgang Hiddemann, Philippe Gaulard, Gilles Salles, Wolfram Klapper, Luc Xerri, Catherine Burton, Reuben M. Tooze, Alexandra G. Smith, Christian Buske, David W. Scott, Yasodha Natkunam, Ranjana Advani, Laurie H. Sehn, John Raemaekers, John Gribben, Sandra Lockmer, Eva Kimby, Marie José Kersten, Delphine Maucort-Boulch, Bauke Ylstra, Erik van Dijk, Daphne de Jong
Diterbitkan 2023-04-01
Artikel